SRC and neoplasm: Importantly, reducing bnl expression in HSD-enhanced Ras/Src-tumours (ras1G12V;csk−/−,bnlRNAi) not only attenuated systemic muscle wasting but also suppressed tumour growth and larval lethality (Fig. 2d–f and Supplementary Fig. 3p).